226 related articles for article (PubMed ID: 10347229)
21. IFT20 modulates ciliary PDGFRα signaling by regulating the stability of Cbl E3 ubiquitin ligases.
Schmid FM; Schou KB; Vilhelm MJ; Holm MS; Breslin L; Farinelli P; Larsen LA; Andersen JS; Pedersen LB; Christensen ST
J Cell Biol; 2018 Jan; 217(1):151-161. PubMed ID: 29237719
[TBL] [Abstract][Full Text] [Related]
22. Fgr but not Syk tyrosine kinase is a target for beta 2 integrin-induced c-Cbl-mediated ubiquitination in adherent human neutrophils.
Melander F; Andersson T; Dib K
Biochem J; 2003 Mar; 370(Pt 2):687-94. PubMed ID: 12435267
[TBL] [Abstract][Full Text] [Related]
23. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription.
Goh EL; Zhu T; Leong WY; Lobie PE
Endocrinology; 2002 Sep; 143(9):3590-603. PubMed ID: 12193575
[TBL] [Abstract][Full Text] [Related]
24. Suppression of c-Cbl tyrosine phosphorylation inhibits neointimal formation in balloon-injured rat arteries.
Tang Z; Wang Y; Fan Y; Zhu Y; Chien S; Wang N
Circulation; 2008 Aug; 118(7):764-72. PubMed ID: 18663086
[TBL] [Abstract][Full Text] [Related]
25. EGF-dependent association of phospholipase C-gamma1 with c-Cbl.
Tvorogov D; Carpenter G
Exp Cell Res; 2002 Jul; 277(1):86-94. PubMed ID: 12061819
[TBL] [Abstract][Full Text] [Related]
26. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
[TBL] [Abstract][Full Text] [Related]
27. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl.
Thien CB; Langdon WY
Oncogene; 1997 Dec; 15(24):2909-19. PubMed ID: 9416834
[TBL] [Abstract][Full Text] [Related]
28. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
[TBL] [Abstract][Full Text] [Related]
29. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M
J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609
[TBL] [Abstract][Full Text] [Related]
30. Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor.
Oksvold MP; Thien CB; Widerberg J; Chantry A; Huitfeldt HS; Langdon WY
Oncogene; 2003 Nov; 22(52):8509-18. PubMed ID: 14627991
[TBL] [Abstract][Full Text] [Related]
31. Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes.
Artemenko Y; Gagnon A; Sorisky A
J Cell Physiol; 2009 Jan; 218(1):228-36. PubMed ID: 18814181
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of fcgamma receptor-mediated phagocytosis by transforming mutants of Cbl.
Sato N; Kim MK; Schreiber AD
J Immunol; 1999 Dec; 163(11):6123-31. PubMed ID: 10570302
[TBL] [Abstract][Full Text] [Related]
33. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk.
Sohn HW; Gu H; Pierce SK
J Exp Med; 2003 Jun; 197(11):1511-24. PubMed ID: 12771181
[TBL] [Abstract][Full Text] [Related]
34. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation.
Galisteo ML; Dikic I; Batzer AG; Langdon WY; Schlessinger J
J Biol Chem; 1995 Sep; 270(35):20242-5. PubMed ID: 7657591
[TBL] [Abstract][Full Text] [Related]
35. The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitination.
Sévère N; Miraoui H; Marie PJ
J Biol Chem; 2011 Jul; 286(27):24443-50. PubMed ID: 21596750
[TBL] [Abstract][Full Text] [Related]
36. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor.
Levkowitz G; Waterman H; Zamir E; Kam Z; Oved S; Langdon WY; Beguinot L; Geiger B; Yarden Y
Genes Dev; 1998 Dec; 12(23):3663-74. PubMed ID: 9851973
[TBL] [Abstract][Full Text] [Related]
37. A gain of function mutation in the activation loop of platelet-derived growth factor beta-receptor deregulates its kinase activity.
Chiara F; Goumans MJ; Forsberg H; Ahgrén A; Rasola A; Aspenström P; Wernstedt C; Hellberg C; Heldin CH; Heuchel R
J Biol Chem; 2004 Oct; 279(41):42516-27. PubMed ID: 15284236
[TBL] [Abstract][Full Text] [Related]
38. Insulin stimulates tyrosine phosphorylation of the proto-oncogene product of c-Cbl in 3T3-L1 adipocytes.
Ribon V; Saltiel AR
Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):839-45. PubMed ID: 9210408
[TBL] [Abstract][Full Text] [Related]
39. A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells.
Lupher ML; Reedquist KA; Miyake S; Langdon WY; Band H
J Biol Chem; 1996 Sep; 271(39):24063-8. PubMed ID: 8798643
[TBL] [Abstract][Full Text] [Related]
40. Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases.
Kowanetz K; Crosetto N; Haglund K; Schmidt MHH; Heldin CH; Dikic I
J Biol Chem; 2004 Jul; 279(31):32786-95. PubMed ID: 15159412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
